Status:

COMPLETED

Anakinra as a Treatment for Hydradenitis Suppurativa

Lead Sponsor:

University of California, San Francisco

Conditions:

Hidradenitis Suppurativa

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is an open-label, proof-of-concept research study to assess the effectiveness of anakinra in the treatment of patients with hidradenitis suppurativa (HS). The planned intervention is to provide a...

Eligibility Criteria

Inclusion

  • 1\) Signed informed consent form with Confirmed diagnosis of hidradenitis suppurativa with moderate or severe disease activity

Exclusion

  • Use of the following therapies:
  • Etanercept in the 4 weeks prior to the baseline visit (Day 1)
  • Adalimumab in the 8 weeks prior to the baseline visit (Day 1)
  • Infliximab in the 12 weeks prior to the baseline visit (Day 1)
  • Any other investigational biologics in the 8 weeks prior to the baseline visit (Day 1)
  • Leflunomide in the 4 weeks prior to the baseline visit (Day 1) • Thalidomide in the 4 weeks prior to the baseline visit (Day 1)
  • Cyclosporine in the 4 weeks prior to the baseline visit (Day 1)
  • I.V. immunoglobulin (I.V. Ig) in the 8 weeks prior to the baseline visit (Day 1)
  • 6-Mercaptopurine, azathioprine, cyclophosphamide, or chlorambucil in the 12 weeks prior to the baseline visit (Day 1)
  • Colchicine, dapsone, mycophenolate mofetil \& systemic antibiotics in the 3 weeks prior to the baseline visit (Day 1)
  • Corticosteroids "20mg/day or \>0.4 mg/kg, whichever applies, in the 1 week prior to the baseline visit (Day 1)
  • history of immunocompromise including HIV infection
  • positive Hep B surface antigen -

Key Trial Info

Start Date :

October 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2013

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT01516749

Start Date

October 1 2012

End Date

July 1 2013

Last Update

August 20 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

San Francisco General Hospital

San Francisco, California, United States, 94110